Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Unlike the state's registered voters, students from 165 schools across the state narrowly favored Democrat Jennifer McCormick ...

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral ...

Movement in our society dropped maybe 80 years ago when we had cars and mass transportation ... start to look at longevity ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

There has been no update from the FTC on its review of the deal since then. Novo Nordisk faces competition from U.S. rival ...

In a perfect universe, the persuasiveness of an argument would not be based mostly on who said it. In the world we live in, ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

"If we're going to be a serious port, then we've got to look at bringing in containers. The container changed the world. It's ...